Dipartimento di Scienze Farmaceutiche Pietro Pratesi, Facoltà di Farmacia, Università degli Studi di Milano, Via Mangiagalli, 25, IT-20133 Milano.
Chem Biodivers. 2009 Nov;6(11):2092-100. doi: 10.1002/cbdv.200900174.
Temocapril is a prodrug whose hydrolysis by carboxylesterase 1 (CES1) yields the active ACE inhibitor temocaprilat. This molecular-dynamics (MD) study uses a resolved structure of the human CES1 (hCES1) to investigate some mechanistic details of temocapril hydrolysis. The ionization constants of temocapril (pK1 and pK3) and temocaprilat (pK1, pK2, and pK3) were determined experimentally and computationally using commercial algorithms. The constants so obtained were in good agreement and revealed that temocapril exists mainly in three ionic forms (a cation, a zwitterion, and an anion), whereas temocaprilat exists in four major ionic forms (a cation, a zwitterion, an anion, and a dianion). All these ionic forms were used as ligands in 5-ns MS simulations. While the cationic and zwitterionic forms of temocapril were involved in an ion-pair bond with Glu255 suggestive of an inhibitor behavior, the anionic form remained in a productive interaction with the catalytic center. As for temocaprilat, its cation appeared trapped by Glu255, while its zwitterion and anion made a slow departure from the catalytic site and a partial egress from the protein. Only its dianion was effectively removed from the catalytic site and attracted to the protein surface by Lys residues. A detailed mechanism of product egress emerges from the simulations.
特莫普利是一种前药,其通过羧酸酯酶 1(CES1)水解生成活性 ACE 抑制剂特莫普利拉。本分子动力学(MD)研究使用人 CES1(hCES1)的解析结构来研究特莫普利水解的一些机制细节。特莫普利(pK1 和 pK3)和特莫普利拉(pK1、pK2 和 pK3)的离解常数通过商业算法进行了实验和计算确定。所获得的常数非常吻合,表明特莫普利主要以三种离子形式存在(阳离子、内盐和阴离子),而特莫普利拉以四种主要离子形式存在(阳离子、内盐、阴离子和二价阴离子)。所有这些离子形式都用作 5-ns MS 模拟中的配体。虽然特莫普利的阳离子和内盐形式与 Glu255 形成离子对键,提示其具有抑制剂行为,但阴离子形式仍与催化中心保持有效相互作用。对于特莫普利拉,其阳离子似乎被 Glu255 捕获,而其内盐和阴离子则从催化位点缓慢离开并从蛋白质中部分逸出。只有其二价阴离子才能有效地从催化位点中移除,并被赖氨酸残基吸引到蛋白质表面。模拟结果揭示了产物逸出的详细机制。